Skip to Main Content

Author Details

Thomas Vallet
Institut Pasteur, Center for the Viral Populations and Pathogenesis
2017
23
12
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38086763Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies.J Enzyme Inhib Med Chem2024
37018377The E2 glycoprotein holds key residues for Mayaro virus adaptation to the urban Aedes aegypti mosquito.PLoS Pathog2023
34705560Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.J Virol2022
35468712Packaging, Purification, and Titration of Replication-Deficient Semliki Forest Virus-Derived Particles as a Self-Amplifying mRNA Vaccine VectorIran Biomed J2022
34914162A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.EMBO Rep2022
35301120An alphavirus-derived self-amplifying mRNA encoding PpSP15-LmSTI1 fusion protein for the design of a vaccine against leishmaniasis.Parasitol Int2022
35022749APOBEC3C S188I Polymorphism Enhances Context-Specific Editing of Hepatitis B Virus Genome.J Infect Dis2022
34214632Quantitative evaluation of PpSP15-LmSTI1 fusion gene expression following transfection with an alphavirus-derived self-amplifying mRNA and conventional DNA vaccine platforms.Mol Cell Probes2021
33791693Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2.bioRxiv2021
33863888Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts.Nat Commun2021
33556143Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes.PLoS Pathog2021
34687604Induced intra- and intermolecular template switching as a therapeutic mechanism against RNA viruses.Mol Cell2021
34326236Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.Science2021
32353859A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.Nature2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
31710653Host nutritional status affects alphavirus virulence, transmission, and evolution.PLoS Pathog2019
29503180Dicer-2-Dependent Generation of Viral DNA from Defective Genomes of RNA Viruses Modulates Antiviral Immunity in Insects.Cell Host Microbe2018
30135220Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by <i>Aedes</i> Mosquitoes.mSphere2018
29853501Complete Genome Sequence of a Novel Recombinant <i>Citrus Tristeza Virus</i>, a Resistance-Breaking Isolate from Uruguay.Genome Announc2018
28581455Attenuation of RNA viruses by redirecting their evolution in sequence space.Nat Microbiol2017
28539441Chikungunya Virus Overcomes Polyamine Depletion by Mutation of nsP1 and the Opal Stop Codon To Confer Enhanced Replication and Fitness.J Virol2017
28343845Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding.Antiviral Res2017
  • 1 - 23 of 23

Recommended Authors

Fundacion Instituto Leloir-CONICET
Career Start Year 2017
Number of shared co-authors 1
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 23
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 1
Wuhan Institute of Virology, Chinese Academy of Sciences
Career Start Year 2012
Number of shared co-authors 2
MRC-University of Glasgow Centre for Virus Research
Career Start Year 2012
Number of shared co-authors 20
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 14
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 5
Brigham Young University
Career Start Year 2009
Number of shared co-authors 3
College of Veterinary Medicine, Kansas State University
Career Start Year 2009
Number of shared co-authors 6
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 0
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 2
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 5
University of North Carolina School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Institute of Tropical Medicine
Career Start Year 2007
Number of shared co-authors 7
University of North Carolina
Career Start Year 2004
Number of shared co-authors 0
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 4
University of California davis
Career Start Year 2002
Number of shared co-authors 10
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 30
The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 4
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 7
University of Michigan ann arbor
Career Start Year 1995
Number of shared co-authors 5
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 4
University College London
Career Start Year 1992
Number of shared co-authors 18
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 6
Fundacion Instituto Leloir-CONICET
Career Start Year 1991
Number of shared co-authors 4
University of Texas Medical Branch
Career Start Year 1983
Number of shared co-authors 4
University of North Carolina
Career Start Year 1981
Number of shared co-authors 4
University of California san francisco
Career Start Year 1981
Number of shared co-authors 12
Rockefeller University
Career Start Year 1981
Number of shared co-authors 13

Collaborators

Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 22
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 8
University of California San Francisco
Co-authored papers 5
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 5
University of California San Francisco
Co-authored papers 5
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 5
Institut Pasteur
Co-authored papers 4
University of Michigan ann arbor
Co-authored papers 4
Institut Pasteur, Universite Paris Cite, CNRS UMR3569
Co-authored papers 4
Pasteur Institute of Iran
Co-authored papers 4
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 4
European Bioinformatics Institute
Co-authored papers 3
University of California san francisco
Co-authored papers 3
J. David Gladstone Institutes
Co-authored papers 3
Institut Pasteur
Co-authored papers 3
Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes
Co-authored papers 3
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 3
J. David Gladstone Institutes
Co-authored papers 3
Fred Hutchinson Cancer Center
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
J. David Gladstone Institutes
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
J. David Gladstone Institutes
Co-authored papers 3
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 3
J. David Gladstone Institutes
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences
Co-authored papers 3
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 3
Emory University
Co-authored papers 3